about
In vivo gene targeting of IL-3 into immature hematopoietic cells through CD117 receptor mediated antibody gene deliveryLipopolyplex for Therapeutic Gene Delivery and Its Application for the Treatment of Parkinson's DiseaseStrategies on the nuclear-targeted delivery of genesEnhanced siRNA delivery using a combination of an arginine-grafted bioreducible polymer, ultrasound, and microbubbles in cancer cells.Identification of a novel cell-penetrating peptide from human phosphatidate phosphatase LPIN3Prospects for nanomedicine in treating age-related macular degeneration.Hydrophobically modified carboxymethyl chitosan nanoparticles targeted delivery of paclitaxel.Enhanced percolation and gene expression in tumor hypoxia by PEGylated polyplex micelles.Ligand-directed targeting of genes to the site of disease.Preparation and characterization of magnetic nanoparticles containing Fe(3)O(4)-dextran-anti-β-human chorionic gonadotropin, a new generation choriocarcinoma-specific gene vector.SV40 Pseudovirion gene delivery of a toxin to treat human adenocarcinomas in mice.Clustered Arg-Gly-Asp peptides enhances tumor targeting of nonviral vectors.Targeted vault nanoparticles engineered with an endosomolytic peptide deliver biomolecules to the cytoplasm.Using inositol as a biocompatible ligand for efficient transgene expression.Biodegradable poly(2-dimethylamino ethylamino)phosphazene for in vivo gene delivery to tumor cells. Effect of polymer molecular weight.Nanoscale polymer carriers to deliver chemotherapeutic agents to tumours.Polymeric oncolytic adenovirus for cancer gene therapy.Membrane and nuclear permeabilization by polymeric pDNA vehicles: efficient method for gene delivery or mechanism of cytotoxicity?Immune cell recruitment and cell-based system for cancer therapy.Intratracheal administration of a nanoparticle-based therapy with the angiotensin II type 2 receptor gene attenuates lung cancer growth.Colloidal microgels in drug delivery applicationsA nanoparticle formulation that selectively transfects metastatic tumors in miceTwenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics.Polycation-functionalized nanoporous silicon particles for gene silencing on breast cancer cells.Targeted siRNA delivery to diseased microvascular endothelial cells: cellular and molecular concepts.Requisites for successful theranostics with radionuclide-based reporter gene imaging.Polyetheylenimine-polyplexes of Spiegelmer NOX-A50 directed against intracellular high mobility group protein A1 (HMGA1) reduce tumor growth in vivo.Bolaamphiphiles: a pharmaceutical review.Gene therapy as a potential tool for treating neuroblastoma-a focused review.Cell-Penetrating Peptides-Mechanisms of Cellular Uptake and Generation of Delivery Systems.Building Cell Selectivity into CPP-Mediated Strategies.Barriers to Liposomal Gene Delivery: from Application Site to the Target.Lipothiophosphoramidates for gene delivery: critical role of the cationic polar headgroup."Soft" calcium crosslinks enable highly efficient gene transfection using TAT peptideA ligand-mediated nanovector for targeted gene delivery and transfection in cancer cells.A convenient and adjustable surface-modified complex containing poly-L-glutamic acid conjugates as a vector for gene delivery.PEI-PEG-Chitosan Copolymer Coated Iron Oxide Nanoparticles for Safe Gene Delivery: synthesis, complexation, and transfection.Combined Local Pulmonary and Systemic Delivery of AT2R Gene by Modified TAT Peptide Nanoparticles Attenuates Both Murine and Human Lung Carcinoma Xenografts in Mice.Lipid nanocapsules functionalized with polyethyleneimine for plasmid DNA and drug co-delivery and cell imaging.Successful target cell transduction of capsid-engineered rAAV vectors requires clathrin-dependent endocytosis.
P2860
Q24801425-2A0ED7EB-0A31-4C1E-91ED-786574EAF487Q26752578-2EF92DDA-C246-4FBA-A2FA-2DD45D57B689Q26852376-A7DC0438-6CD1-4380-994F-C7DABD006BEEQ30438863-0C3AE22F-252F-42C0-B40E-FD6C7544E45EQ30564015-CE6B0F2E-5752-4A0A-AD3F-6E7FAFC5FC9BQ33424022-3B0B5370-04FD-4435-A4C1-FD3242014A61Q33549485-9BF3FCD6-6E7C-41CC-A5F0-38D527BADAA0Q33713888-9AD5054E-B87A-4AE7-9FAA-E51CDC96430FQ34168868-EB769747-F719-4683-9135-F3A42B481718Q34601248-6ED96C34-7B06-402B-B025-5A3F40E92042Q34695978-56EC411B-918B-412C-9640-B9CC35F7EEEBQ34812125-ECDE26F1-AA3F-4BF5-ABCA-A8A429F95CFBQ35185966-E8130D41-AEE0-444D-A915-21062C3C4BA4Q35491335-E22F188C-93C8-4C04-BF24-AB707361746FQ35884341-79395A17-B389-4897-98F1-CBF98CAE26C2Q36327049-8A5B8492-7477-4114-84F0-341C0B234730Q36344901-8296AD04-6236-470C-B400-544C8AD7C887Q36474508-201ABE5C-28E6-45C6-91FA-1464000761D1Q36517706-24711C95-17A4-49F8-81EA-3900B9AD1B90Q36594271-1DA5606F-4EA1-48D6-8104-47D57887372AQ36683664-70A2FFE5-E16F-4BBF-B8D3-7355E83D0C92Q37157373-CAA005CB-6375-41E7-89E3-D5497125BB3CQ37230918-152357DF-064A-4B27-AACD-F0C0B607CBE8Q37347118-C11C9B57-0040-47AA-A6D5-0034B4A35B9AQ37902117-706882D9-1E66-43D7-9EEF-69BC33E1637BQ38177892-FE720A3C-7BCC-49DA-8347-1893C310598AQ38339945-5D180B1B-EE10-4842-AE0A-6C93B55DEF94Q38351743-938ED621-FC3A-4E6B-A978-156141F70FF3Q38808728-59DA2FA1-1BCF-43C5-9F17-787410A8D382Q38974236-A5CD4691-7463-42F1-BB2D-1210A4E8DD39Q38974301-C1454C87-E799-41B5-BC62-B28452CE4A98Q39147224-CDAA56CE-470B-4439-B767-DDA5B73E65EDQ39403585-03B98935-0529-498A-A70A-BEC0D30356F7Q39793490-9C62CA27-90EA-4584-AC11-78358EEC4D98Q39920259-0519596F-2681-4256-B338-84B621D57FA7Q39953063-26AB2254-1820-430A-BBE9-1602C2FFBEDAQ41969804-5EBFC1E0-EB23-49B1-B003-CCA5EBAFE541Q45861165-3D0FEFD2-5A4C-4F2E-9F39-C1001F0BC745Q45865485-26BA043F-EB46-4E5C-92C3-87BEBD1CCB7BQ45870768-25386526-7707-4EA8-9901-667DC02FAD83
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Targeting tumors with non-viral gene delivery systems.
@ast
Targeting tumors with non-viral gene delivery systems.
@en
Targeting tumors with non-viral gene delivery systems.
@nl
type
label
Targeting tumors with non-viral gene delivery systems.
@ast
Targeting tumors with non-viral gene delivery systems.
@en
Targeting tumors with non-viral gene delivery systems.
@nl
prefLabel
Targeting tumors with non-viral gene delivery systems.
@ast
Targeting tumors with non-viral gene delivery systems.
@en
Targeting tumors with non-viral gene delivery systems.
@nl
P1433
P1476
Targeting tumors with non-viral gene delivery systems
@en
P2093
Manfred Ogris
P304
P356
10.1016/S1359-6446(02)02243-2
P50
P577
2002-04-01T00:00:00Z